Samaritan Pharmaceuticals Company Logo
Samaritan to Highlight Oral HIV Entry Inhibitor and Novel Alzheimer's Drug At BioPartnering Europe to Seek Partnering Opportunities
October 03, 2006 09:30 ET | Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will highlight the uniqueness and advantages of its oral HIV...
Viral Genetics, Inc. Provides Update on Phase 3 Trial of VGV-1 in South Africa
July 21, 2005 10:00 ET | Viral Genetics, Inc.
AZUSA, Calif., July 21, 2005 (PRIMEZONE) -- Viral Genetics, Inc. (OTCBB:VRAL), a drug development company developing a biologic therapy for HIV infection, today announced that the eight-week,...